APRIN is a cell cycle specific BRCA2‐interacting protein required for genome integrity and a predictor of outcome after chemotherapy in breast cancer

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

Hannah Farmer, Nuala McCabe, Christopher J. Lord et al. · Nature · 2005 · 6.7K citations

Life Sciences, Genetics, Molecular Biology +16

pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐up

C.W. Elston, Ian O. Ellis · Histopathology · 1991 · 6.2K citations

Medicine, Oncology, Pathology +17

Multiple sequence alignment with the Clustal series of programs

Nucleic Acids Research · 2003 · 4.9K citations · Full text

Life Sciences, Bioinformatics, Molecular Biology +14

ATM and ATR Substrate Analysis Reveals Extensive Protein Networks Responsive to DNA Damage

Shuhei Matsuoka, Bryan A. Ballif, Agata Smogorzewska et al. · Science · 2007 · 3.1K citations

Life Sciences, Cell Biology, Molecular Biology +17

Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma

Torsten O. Nielsen, Forrest D. Hsu, Kristin C. Jensen et al. · Clinical Cancer Research · 2004 · 2.7K citations · Full text

Medicine, Oncology, Pathology +17